Patents Assigned to Conrig Pharma ApS
  • Composition comprising suplatast tosilate
    Patent number: 11819482
    Abstract: Provided is a pharmaceutical composition comprising suplatast tosilate or pharmaceutically acceptable derivatives thereof that provides for a constant exposure of the compound.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: November 21, 2023
    Assignees: Conrig Pharma ApS, Solural Pharma ApS
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Bent Højgaard
  • Suplatast tosilate for use in the treatment of cough associated with interstitial lung disease
    Patent number: 11690814
    Abstract: Provided is a composition comprising suplatast tosilate or pharmaceutically acceptable derivatives thereof for use in a method of treating cough associated with interstitial lung disease, such as cough associated with pulmonary fibrosis.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: July 4, 2023
    Assignee: CONRIG PHARMA APS
    Inventors: John Bondo Hansen, Mikael S. Thomsen, Niels Skjærbæk
  • DEUTERATED 5-HT1A RECEPTOR AGONISTS
    Publication number: 20130303497
    Abstract: The present invention relates to new deuterated derivatives of serotonin 5-HT1A receptor agonists of formula 1 and in particular to compositions and methods for therapeutic use.
    Type: Application
    Filed: August 4, 2011
    Publication date: November 14, 2013
    Applicant: Conrig Pharma ApS
    Inventors: John Bondo Hansen, Mikael Søndergaard Thomsen